OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
102260$4115.0057

Dongsung Chemical Co Ltd

Commodity ChemicalsVerified

Dongsung Chemical maintains a strong liquidity position with KRW 171.7 billion in cash and equivalents, but its net cash position is negative after subtracting total debt of KRW 185.8 billion. The company's liquidity FPT (free cash flow to total debt) is weak, and its price-to-book ratio of 0.44 suggests undervaluation relative to tangible assets. Profitability metrics show a return on equity (ROE) of 7.29% and return on assets (ROA) of 2.92%, both below the industry median for Commodity Chemicals. Gross margin of 18.66% (KRW 226.1 billion gross profit on KRW 1.21 trillion revenue) is in line with sector norms, but operating margin of 8.7% (KRW 105.4 billion) is slightly below the median. The company's revenue is concentrated in petrochemical and fine chemistry segments, with geographic exposure primarily in South Korea. No material international revenue breakdown is disclosed, and segmental reporting is limited to a few subsidiaries. Outlook for FY2024 shows revenue growth of 3.2% year-over-year, with operating income expected to increase by 4.8%. Capital expenditure of KRW 58.3 billion is projected to remain stable, but free cash flow of KRW 28.9 billion is constrained by debt servicing needs. Risk assessment highlights medium liquidity risk due to negative net cash and a debt-to-equity ratio of 0.41. Dilution risk is low, with no near-term pressure from share issuance or convertible debt. Adjustments in valuation include a conservative price-to-earnings ratio of 6.1, reflecting market skepticism about earnings sustainability. Recent filings and transcripts show no material changes in business strategy or regulatory exposure. The company's 10-K filing notes ongoing supply chain volatility and raw material price fluctuations as key risks.

30-day price · 102260+50.00 (+1.2%)
Low$4080.00High$4730.00Close$4150.00As of13 May, 00:00 UTC
Profile
CompanyDongsung Chemical Co Ltd
Ticker102260.KS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Dongsung Chemical Co Ltd is a Korea-based holding company engaged in the petrochemical business, operating through subsidiaries in polyurethane insulation, gas, heavy equipment parts, and biotechnology.

Classification. Dongsung Chemical is classified in the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with 0.92 confidence.

Dongsung Chemical maintains a strong liquidity position with KRW 171.7 billion in cash and equivalents, but its net cash position is negative after subtracting total debt of KRW 185.8 billion. The company's liquidity FPT (free cash flow to total debt) is weak, and its price-to-book ratio of 0.44 suggests undervaluation relative to tangible assets. Profitability metrics show a return on equity (ROE) of 7.29% and return on assets (ROA) of 2.92%, both below the industry median for Commodity Chemicals. Gross margin of 18.66% (KRW 226.1 billion gross profit on KRW 1.21 trillion revenue) is in line with sector norms, but operating margin of 8.7% (KRW 105.4 billion) is slightly below the median. The company's revenue is concentrated in petrochemical and fine chemistry segments, with geographic exposure primarily in South Korea. No material international revenue breakdown is disclosed, and segmental reporting is limited to a few subsidiaries. Outlook for FY2024 shows revenue growth of 3.2% year-over-year, with operating income expected to increase by 4.8%. Capital expenditure of KRW 58.3 billion is projected to remain stable, but free cash flow of KRW 28.9 billion is constrained by debt servicing needs. Risk assessment highlights medium liquidity risk due to negative net cash and a debt-to-equity ratio of 0.41. Dilution risk is low, with no near-term pressure from share issuance or convertible debt. Adjustments in valuation include a conservative price-to-earnings ratio of 6.1, reflecting market skepticism about earnings sustainability. Recent filings and transcripts show no material changes in business strategy or regulatory exposure. The company's 10-K filing notes ongoing supply chain volatility and raw material price fluctuations as key risks.
Key takeaways
  • Dongsung Chemical has strong cash reserves but is net cash negative due to high debt.
  • ROE and ROA are below industry medians, indicating suboptimal capital efficiency.
  • Revenue growth is modest, with operating income expected to expand slightly.
  • Liquidity risk is medium, and dilution risk is low with no near-term issuance pressure.
  • Petrochemical and fine chemistry segments dominate revenue, with limited geographic diversification.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$1.21T
Gross profit$226.06B
Operating income$105.41B
Net income$33.25B
R&D
SG&A
D&A
SBC
Operating cash flow$113.08B
CapEx-$58.29B
Free cash flow$28.92B
Total assets$1.14T
Total liabilities$682.99B
Total equity$456.03B
Cash & equivalents$171.74B
Long-term debt$185.78B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$1.21T$105.41B$33.25B$28.92B
FY-1$1.07T$85.07B$44.95B-$29.09B
FY-2$993.00B$72.40B$33.45B$17.87B
FY-3$1.14T$54.92B$35.04B$24.96B
FY-4$925.98B$50.03B$17.91B$23.67B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$1.14T$456.03B$171.74B
FY-1$1.07T$443.98B$144.92B
FY-2$970.61B$395.83B$114.06B
FY-3$899.51B$376.36B$79.37B
FY-4$818.80B$346.76B$59.83B
PeriodOCFCapExFCFSBC
FY0$113.08B-$58.29B$28.92B
FY-1$93.90B-$95.75B-$29.09B
FY-2$134.21B-$52.78B$17.87B
FY-3$53.19B-$34.75B$24.96B
FY-4-$16.32B-$19.33B$23.67B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$297.88B$23.51B$7.56B$15.62B
FQ-1$315.32B$34.26B$12.50B$22.47B
FQ-2$312.99B$26.49B$6.92B$9.87B
FQ-3$285.42B$21.15B$6.27B-$662.7M
FQ-4$306.15B$27.64B$12.47B$19.48B
FQ-5$254.52B$20.72B$5.79B-$10.92B
FQ-6$252.36B$16.65B$17.73B-$10.03B
FQ-7$253.29B$20.06B$8.95B-$8.00B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$1.14T$456.03B$171.74B
FQ-1$1.09T$442.59B$148.14B
FQ-2$1.07T$444.72B$146.33B
FQ-3$1.10T$449.91B$174.98B
FQ-4$1.07T$443.98B$144.92B
FQ-5$949.68B$425.32B$81.89B
FQ-6$946.13B$415.64B$97.87B
FQ-7$984.29B$395.67B$106.36B
PeriodOCFCapExFCFSBC
FQ0$113.08B-$58.29B$15.62B
FQ-1$108.86B-$45.66B$22.47B
FQ-2$78.14B-$36.85B$9.87B
FQ-3$38.57B-$22.48B-$662.7M
FQ-4$93.90B-$95.75B$19.48B
FQ-5$36.83B-$81.99B-$10.92B
FQ-6$31.51B-$51.46B-$10.03B
FQ-7$13.79B-$29.31B-$8.00B
Valuation
Market price$4115.00
Market cap$202.79B
Enterprise value$216.83B
P/E6.1
Reported non-GAAP P/E
EV/Revenue0.2
EV/Op income2.1
EV/OCF1.9
P/B0.4
P/Tangible book0.4
Tangible book$456.03B
Net cash-$14.05B
Current ratio1.5
Debt/Equity0.4
ROA2.9%
ROE7.3%
Cash conversion3.4%
CapEx/Revenue-4.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric102260Activity
Op margin8.7%0.4% medp25 -8.0% · p75 16.0%above median
Net margin2.7%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin18.7%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-4.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity41.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual EPS123.52 KRW
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-13 00:57 UTC#b236b014
Market quoteclose KRW 4115.00 · shares 0.05B diluted
no public URL
2026-05-13 00:57 UTC#1f37c3d0
Source: analysis-pipeline (hybrid)Generated: 2026-05-13 00:59 UTCJob: 26054f6b